Second Review Aims to Improve Targeting Accuracy
Double-Tracer “Diagnostic Twins” Could Improve Alpha-Targeted Prostate Cancer Dosing When metastatic prostate cancer outpaces hormonal therapy, clinicians face a narrow set of options. Targeted alpha therapy with Actinium-225 offers a sharp promise:...
Read moreDetails

